BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2156852)

  • 21. Regulation of urokinase receptors in monocytelike U937 cells by phorbol ester phorbol myristate acetate.
    Picone R; Kajtaniak EL; Nielsen LS; Behrendt N; Mastronicola MR; Cubellis MV; Stoppelli MP; Pedersen S; Danø K; Blasi F
    J Cell Biol; 1989 Feb; 108(2):693-702. PubMed ID: 2537321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA.
    Barnathan ES; Kuo A; Karikó K; Rosenfeld L; Murray SC; Behrendt N; Rønne E; Weiner D; Henkin J; Cines DB
    Blood; 1990 Nov; 76(9):1795-806. PubMed ID: 2171700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the binding of pro-urokinase and urokinase-plasminogen activator inhibitor-1 complex to the low density lipoprotein receptor-related protein using a Fab fragment selected from a phage-displayed Fab library.
    Horn IR; Moestrup SK; van den Berg BM; Pannekoek H; Nielsen MS; van Zonneveld AJ
    J Biol Chem; 1995 May; 270(20):11770-5. PubMed ID: 7538122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Secretion of a variant of human single-chain urokinase-type plasminogen activator without an N-glycosylation site in the methylotrophic yeast, Pichia pastoris and characterization of the secreted product.
    Tsujikawa M; Okabayashi K; Morita M; Tanabe T
    Yeast; 1996 May; 12(6):541-53. PubMed ID: 8771709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR; De Cock F; Collen D
    Eur J Biochem; 1994 Sep; 224(2):567-74. PubMed ID: 7925373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes.
    Stoppelli MP; Corti A; Soffientini A; Cassani G; Blasi F; Assoian RK
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):4939-43. PubMed ID: 2991901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specific binding of urinary-type plasminogen activator (u-PA) to vitronectin and its role in mediating u-PA-dependent adhesion of U937 cells.
    Moser TL; Enghild JJ; Pizzo SV; Stack MS
    Biochem J; 1995 May; 307 ( Pt 3)(Pt 3):867-73. PubMed ID: 7537960
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.
    Bakker AH; Nieuwenbroek NM; Verheijen JH
    Protein Eng; 1995 Dec; 8(12):1295-1302. PubMed ID: 8869642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urokinase synthesis and binding by glomerular epithelial cells in culture.
    Rondeau E; Ochi S; Lacave R; He CJ; Medcalf R; Delarue F; Sraer JD
    Kidney Int; 1989 Oct; 36(4):593-600. PubMed ID: 2554052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential inhibition of soluble and cell surface receptor-bound single-chain urokinase by plasminogen activator inhibitor type 2. A potential regulatory mechanism.
    Schwartz BS
    J Biol Chem; 1994 Mar; 269(11):8319-23. PubMed ID: 7907591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescent probes as tools to assess the receptor for the urokinase-type plasminogen activator on tumor cells.
    Schmitt M; Chucholowski N; Busch E; Hellmann D; Wagner B; Goretzki L; Jänicke F; Günzler WA; Graeff H
    Semin Thromb Hemost; 1991 Jul; 17(3):291-302. PubMed ID: 1724574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
    Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
    Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
    Vandamme AM; Dewerchin M; Lijnen HR; Bernar H; Bulens F; Nelles L; Collen D
    Eur J Biochem; 1992 Apr; 205(1):139-46. PubMed ID: 1313361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular receptor for urokinase-type plasminogen activator: protein structure.
    Behrendt N; Ploug M; Rønne E; Høyer-Hansen G; Danø K
    Methods Enzymol; 1993; 223():207-22. PubMed ID: 8271954
    [No Abstract]   [Full Text] [Related]  

  • 35. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA; Medcalf RL; Kruithof EK
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of a chimeric plasminogen activator consisting of amino acids 1 to 274 of tissue-type plasminogen activator and amino acids 138 to 411 of single-chain urokinase-type plasminogen activator.
    Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
    J Biol Chem; 1988 Dec; 263(35):19083-91. PubMed ID: 3143723
    [TBL] [Abstract][Full Text] [Related]  

  • 37. cDNA for Mo3, a monocyte activation antigen, encodes the human receptor for urokinase plasminogen activator.
    Min HY; Semnani R; Mizukami IF; Watt K; Todd RF; Liu DY
    J Immunol; 1992 Jun; 148(11):3636-42. PubMed ID: 1316922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of a fusion protein consisting of amino acids 1 to 263 of tissue-type plasminogen activator and amino acids 144 to 411 of urokinase-type plasminogen activator.
    Nelles L; Lijnen HR; Collen D; Holmes WE
    J Biol Chem; 1987 Aug; 262(22):10855-62. PubMed ID: 2956260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a nonglycosylated single chain urinary plasminogen activator secreted from yeast.
    Melnick LM; Turner BG; Puma P; Price-Tillotson B; Salvato KA; Dumais DR; Moir DT; Broeze RJ; Avgerinos GC
    J Biol Chem; 1990 Jan; 265(2):801-7. PubMed ID: 2104831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
    Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
    Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.